Skip to main content

About Kenneth Cornell

After earning a Ph.D. in Biochemistry and Molecular Biology from Oregon Health Sciences University, and serving as a Postdoctoral Fellow in Molecular Immunology at the Portland (OR) VA Medical Center, Dr. Ken Cornell joined the faculty of the Department of Chemistry and Biochemistry at Boise State University in 2004. Dr. Cornell's research interests include antibiotic development targeting bacterial and parasite methionine salvage, farnesol metabolism in eukaryotic cells, and development of forensic reagents. One of the primary investigations in his lab is the identification of new targets for antimicrobial drug development.
Some of Dr. Cornell's current ongoing research support includes “A West Nile Virus Vaccine” Agency: DOD/CDMRP, Date: 09/09-08/10($940,000), “Global Consequences of Interruption of Microbial Autoinducer Signaling” Agency: NIH / Idaho INBRE, Date: 5/09-4/14 ($352,000), and “Acquisition of a Liquid Chromatography Tandem Mass Spectrometer” Agency: NSF MRI, Date: 08/09–07/12 ($597,877).

Positions

Present Associate Professor, Department of Chemistry and Biochemistry, Boise State University
to
January 2017 Visiting Professor, University of San Agustin
to

Disciplines


Research Interests


Honors and Awards

  • 1994-1996 NIH Molecular Hematology Predoctoral Fellowship, Dept. of Hematology, Oregon Health Sciences University
  • 1992 & Cell Biology Fellowship, Oregon Health Sciences University


Contact Information

phone:(208)426-5429

Email:


Articles (15)

Conference Proceedings (1)

Presentations (4)